NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Chongqing Lummy Pharmaceutical Co. Ltd (SHE: 300006)
300006 Technical Analysis
5
As on 27th Nov 2024 300006 STOCK Price closed @ 5.82 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 3.47 & Strong Buy for SHORT-TERM with Stoploss of 3.52 we also expect STOCK to react on Following IMPORTANT LEVELS. |
300006STOCK Price
Open | 5.37 | Change | Price | % |
High | 5.82 | 1 Day | 0.97 | 20.00 |
Low | 4.96 | 1 Week | 1.27 | 27.91 |
Close | 5.82 | 1 Month | 2.09 | 56.03 |
Volume | 119260422 | 1 Year | 2.09 | 56.03 |
52 Week High 5.27 | 52 Week Low 2.20 |
SHE China Most Active Stocks
002131 | 3.04 | 10.14% |
300459 | 7.68 | 20.00% |
300059 | 26.41 | 5.05% |
000564 | 2.75 | 3.00% |
002467 | 8.09 | 10.07% |
002195 | 3.67 | -1.87% |
000725 | 4.30 | 2.63% |
300315 | 6.62 | 10.33% |
000100 | 4.65 | 2.65% |
002400 | 8.45 | -1.05% |
SHE China Top Gainers Stocks
SHE China Top Losers Stocks
300006 Daily Charts |
300006 Intraday Charts |
Whats New @ Bazaartrend |
300006 Free Analysis |
|
300006 Important Levels Intraday
RESISTANCE | 7.48 |
RESISTANCE | 6.95 |
RESISTANCE | 6.62 |
RESISTANCE | 6.29 |
SUPPORT | 5.35 |
SUPPORT | 5.02 |
SUPPORT | 4.69 |
SUPPORT | 4.16 |
300006 Forecast November 2024
4th UP Forecast | 6.49 |
3rd UP Forecast | 6.28 |
2nd UP Forecast | 6.14 |
1st UP Forecast | 6.01 |
1st DOWN Forecast | 5.63 |
2nd DOWN Forecast | 5.5 |
3rd DOWN Forecast | 5.36 |
4th DOWN Forecast | 5.15 |
300006 Weekly Forecast
4th UP Forecast | 6.59 |
3rd UP Forecast | 6.34 |
2nd UP Forecast | 6.19 |
1st UP Forecast | 6.04 |
1st DOWN Forecast | 5.60 |
2nd DOWN Forecast | 5.45 |
3rd DOWN Forecast | 5.30 |
4th DOWN Forecast | 5.05 |
300006 Forecast2024
4th UP Forecast | 13.12 |
3rd UP Forecast | 10.78 |
2nd UP Forecast | 9.33 |
1st UP Forecast | 7.89 |
1st DOWN Forecast | 3.75 |
2nd DOWN Forecast | 2.31 |
3rd DOWN Forecast | 0.86 |
4th DOWN Forecast | -1.48 |
Chongqing Lummy Pharmaceutical Co. Ltd ( SHE China Symbol : 300006 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
300006 Other Details
Segment | EQ | |
Market Capital | 5638559744.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-General | |
Offical website | > echo $website ; ?> |
300006 Address
300006 Latest News
300006 Business Profile
Chongqing Lummy Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products in China. The company provides tumor, antibacterial, antiviral, and antifungal, as well as liver disease auxiliary, endocrinology system, and Chinese patent drugs; digestive system, immune system, blood system, cardiovascular system, and nervous system drugs; acid-base balance and nutritional products; and base large infusion products, American ginseng systems, and active pharmaceutical ingredients. Chongqing Lummy Pharmaceutical Co., Ltd. was founded in 1999 and is based in Chongqing, China. Address: Yu Ma Road No. 99, Chongqing, China, 401336
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service